\documentclass[aspectratio=169,xcolor=dvipsnames]{beamer}

\mode<presentation>
{
  \usetheme{default}

  \usecolortheme{default}
  \usefonttheme{default}
  \useinnertheme{circles}

  \setbeamertemplate{navigation symbols}{}
  \setbeamertemplate{caption}[numbered]

  \setbeamertemplate{title page}[default][center]
  \setbeamercolor{title}{fg=black}
  \setbeamercolor{subtitle}{fg=black}
  \setbeamercolor{author}{fg=black}
  \setbeamercolor{date}{fg=black}

  \setbeamertemplate{frametitle}[default][leftskip=1.0cm]
  \setbeamercolor{frametitle}{fg=black}
  
  \setbeamertemplate{footline}[text line]{\color{white}\raisebox{9.75pt}{\hspace{-25pt}\insertframenumber/\inserttotalframenumber}}
}

\usepackage{amsmath}
\usepackage{amssymb}
\usepackage[english]{babel}
\usepackage{hyperref}
\usepackage{listings}
\usepackage{mathrsfs}
\usepackage[mathscr]{euscript}
\usepackage[normalem]{ulem}
\usepackage{pifont}
\usepackage[utf8x]{inputenc}

\newcommand{\cmark}{\ding{51}}
\newcommand{\xmark}{\ding{55}}

\hypersetup{colorlinks=true,citecolor=black,linkcolor=black,urlcolor=blue}

\title[]{Drug Resource Comparison}
\subtitle[]{ChEMBL, NCATS Inxight Drugs, Open Targets}
\author{Raymond LeClair}
\date{Working Copy of May 19, 2025}

\begin{document}

{
  \usebackgroundtemplate{\includegraphics[width=\paperwidth]{NLM-2024-Title-Background.png}}
  \setbeamertemplate{footline}{}
  \begin{frame}
    \vspace{6\baselineskip}
    \titlepage
  \end{frame}
}

\setcounter{framenumber}{0}

\usebackgroundtemplate{\includegraphics[width=\paperwidth,height=\paperheight]{NLM-2024-Slide-Background.png}}

% \begin{frame}{Outline}
%   \tableofcontents[sectionstyle=show,subsectionstyle=hide]
% \end{frame}

% \begin{frame}{Outline}
%   \tableofcontents[sectionstyle=show/shaded,subsectionstyle=show/shaded/hide]
% \end{frame}

\begin{frame}
  \frametitle{Purpose and Approach}
  \framesubtitle{}
  \begin{itemize}
  \item[] Purpose
    \begin{itemize}
    \item Compare how comprehensive, organized, and accessible results
      from each resource appear
    \item Demonstrate use of drug resource APIs using Python
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] Approach
    \begin{itemize}
    \item Follow gene target to approved drugs and disease indications
    \item Investigate gene target ADRB2, approved drug Albuterol, and
      disease Asthma
    \item Provide data samples for review, and comment by team members
    \end{itemize}
  \end{itemize}
\end{frame}

\begin{frame}
  \frametitle{Descriptions and Management (1 of 2)}
  \framesubtitle{}
  \begin{itemize}
  \item[] \href{https://www.ebi.ac.uk/chembl/}{ChEMBL}
    \begin{itemize}
    \item ``A manually curated database of bioactive molecules with
      drug-like properties''
    \item Managed by European Molecular Biology Laboratory-European
      Bioinformatics Institute (EMBL-EBI)
      \href{https://www.ebi.ac.uk/about/teams/chemical-biology-services/}{Chemical
        Biology Services}
    \item Twenty-four team members supporting four services
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] \href{https://drugs.ncats.io/}{NCATS Inxight Drugs}
    \begin{itemize}
    \item ``A comprehensive portal for drug development information''
    \item Managed by \href{https://drugs.ncats.io/about}{NCATS/NIH,
      Division of Preclinical Innovation, IFX Core}
    \item Two team members supporting one service
    \end{itemize}
  \end{itemize}
\end{frame}

\begin{frame}
  \frametitle{Descriptions and Management (2 of 2)}
  \framesubtitle{}
  \begin{itemize}
  \item[]
    \href{https://platform-docs.opentargets.org/getting-started}{Open
      Targets Platform}
    \begin{itemize}
    \item ``A comprehensive tool that supports systematic
      identification and prioritisation of potential therapeutic drug
      targets''
    \item Managed by a consortium of
      \href{https://www.opentargets.org/partners}{partner
        institutions} including EMBL-EBI, Genentech, GSK, MSD, Pfizer,
      Sanofi, Wellcome Sanger Institute
    \item Forty-seven team members supporting one service
    \end{itemize}
    \vspace{4\baselineskip}
  \end{itemize}
\end{frame}

\begin{frame}
  \frametitle{Why consider Open Targets?}
  \framesubtitle{Or, why no Albuterol? And what's with those EFO terms?}
  \begin{itemize}
  \item[] Why no Albuterol?
    \begin{itemize}
    \item Open Targets identifies ADRB2 as the only target for
      Albuterol, while NCATS Inxight also identifies ADRB1
    \item ADRB2 and ADRB1 do not appear in the NSForest binary or
      marker gene results
    \item Since we search for drugs associated with these genes, the
      search does not find Albuterol
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] And the EFO terms?
    \begin{itemize}
    \item The \href{https://www.ebi.ac.uk/efo/}{Experimental Factor
      Ontology} (EFO) describes many experimental variables in EBI
      databases
    \item The EFO serves as the core ontology for Open Targets
    \item Cross references are provided to many other ontologies,
      including MONDO
    \end{itemize}
  \end{itemize}
\end{frame}

\begin{frame}
  \frametitle{\href{https://www.ebi.ac.uk/chembl/}{ChEMBL} API and
    Example Use}
  \framesubtitle{See
    \href{https://github.com/ralatsdc/springbok-drug-resource-comparison}{springbok-drug-resource-comparison}
    repository}
  \begin{itemize}
  \item[] \textbf{API}: Data Web Services
    \href{https://chembl.gitbook.io/chembl-interface-documentation/web-services/chembl-data-web-services}{documentation},
    Python client
    \href{https://github.com/chembl/chembl_webresource_client}{repository}
    (not actively developed), and webresource client
    \href{http://beta.mybinder.org/v2/gh/chembl/chembl_webresource_client/master?filepath=demo_wrc.ipynb}{examples}
    \vspace{0.5\baselineskip}
  \item[] \textbf{Usage}: {\texttt chembl.py [-h] [--gene-symbol GENE\_SYMBOL]
    [-f]}
    \begin{itemize}
    \item Get ChEMBL target id for a gene symbol
    \item Get ChEMBL molecule ids for a target id
    \item Get drugs and drug indications for all molecule ids
    \item Get SVG image for a drug
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] \textbf{Performance}: Got ChEMBL target data for ADRB2 in 383 s on
    the first request, and under 3 s on the second request, suggesting
    the responses are cached
  \end{itemize}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{ChEMBL Activity Data for ADRB2}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
    \vspace{-2\baselineskip}
\begin{verbatim}
"activity": [
  {
    "action_type": null,
    "activity_comment": null,
    "activity_id": 52694,
    "activity_properties": [],
    "assay_chembl_id": "CHEMBL652493",
    "assay_description": "Binding affinity against adrenergic
        receptor subtype Beta-2 adrenergic receptor using
        [3H]DHA as radioligand",
    "assay_type": "B",
    "assay_variant_accession": null,
    "assay_variant_mutation": null,
    "bao_endpoint": "BAO_0000192",
    "bao_format": "BAO_0000357",
    "bao_label": "single protein format",
    "canonical_smiles": "COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c
        (sc5cccnc54)c3=O)C[C@@H]21",
    "data_validity_comment": null,
    "data_validity_description": null,
    "document_chembl_id": "CHEMBL1130166",
    "document_journal": "J Med Chem",
    "document_year": 1997,
    "ligand_efficiency": {
        "bei": "12.07",
        "le": "0.23",
        "lle": "2.44",
        "sei": "6.75"
    },
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
    \vspace{-2\baselineskip}
\begin{verbatim}
    "molecule_chembl_id": "CHEMBL40650",
    "molecule_pref_name": null,
    "parent_molecule_chembl_id": "CHEMBL40650",
    "pchembl_value": "5.41",
    "potential_duplicate": 0,
    "qudt_units": "http://www.openphacts.org/units/Nanomolar",
    "record_id": 199469,
    "relation": "=",
    "src_id": 1,
    "standard_flag": 1,
    "standard_relation": "=",
    "standard_text_value": null,
    "standard_type": "Ki",
    "standard_units": "nM",
    "standard_upper_value": null,
    "standard_value": "3870.0",
    "target_chembl_id": "CHEMBL210",
    "target_organism": "Homo sapiens",
    "target_pref_name": "Beta-2 adrenergic receptor",
    "target_tax_id": "9606",
    "text_value": null,
    "toid": null,
    "type": "Ki",
    "units": "nM",
    "uo_units": "UO_0000065",
    "upper_value": null,
    "value": "3870.0"
  }
]    
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{ChEMBL Drug Data for Albuterol (1 of 2)}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
{
    "applicants": [
        "Dash Pharmaceuticals Llc A Fully Owned Sub Of
            Natco Pharma Ltd",
    ],
    "atc_classification": [
        {
            "code": "R03AC02",
            "description": "RESPIRATORY SYSTEM: DRUGS FOR
                OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS,
                INHALANTS: Selective beta-2-adrenoreceptor
                agonist"
        },
    ],
    "availability_type": 1,
    "biotherapeutic": null,
    "black_box": 1,
    "black_box_warning": "1",
    "chirality": 0,
    "drug_type": 1,
    "first_approval": 1981,
    "first_in_class": 0,
    "helm_notation": null,
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "indication_class": "Bronchodilator",
    "max_phase": "4.0",
    "molecule_chembl_id": "CHEMBL714",
    "ob_patent": "7105152",
    "oral": 1,
    "parenteral": 0,
    "prodrug": 0,
    "research_codes": [
        "SCH-13949W",
    ],
    "rule_of_five": 1,
    "sc_patent": "US-7105152-B1",
    "synonyms": [
        "Albuterol sulfate (MI, USAN, USP)",
    ],
    "topical": 1,
    "usan_stem": "-terol",
    "usan_stem_definition": "bronchodilators
        (phenethylamine derivatives)",
    "usan_stem_substem": "-terol(-terol)",
    "usan_year": 1971,
    "withdrawn_flag": "0"
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{ChEMBL Drug Data for Albuterol (2 of 2)}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "molecule_properties": {
        "alogp": "1.31",
        "aromatic_rings": 1,
        "cx_logd": "-1.32",
        "cx_logp": "0.34",
        "cx_most_apka": "10.12",
        "cx_most_bpka": "9.40",
        "full_molformula": "C13H21NO3",
        "full_mwt": "239.31",
        "hba": 4,
        "hba_lipinski": 4,
        "hbd": 4,
        "hbd_lipinski": 4,
        "heavy_atoms": 17,
        "molecular_species": "BASE",
        "mw_freebase": "239.31",
        "mw_monoisotopic": "239.1521",
        "np_likeness_score": "0.56",
        "num_lipinski_ro5_violations": 0,
        "num_ro5_violations": 0,
        "psa": "72.72",
        "qed_weighted": "0.64",
        "ro3_pass": "N",
        "rtb": 4
    },
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "molecule_structures": {
        "canonical_smiles": "CC(C)(C)NCC(O)c1ccc(O)c(CO)c1",
        "molfile": "...",
        "standard_inchi": "InChI=1S/C13H21NO3/c1-13(2,3)14-7-
            12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-
            8H2,1-3H3",
        "standard_inchi_key": "NDAUXUAQIAJITI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [
        {
            "molecule_synonym": "Accuneb",
            "syn_type": "OTHER",
            "synonyms": "Accuneb"
        },
    ],
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{ChEMBL Drug Indication Data for Albuterol}
  \framesubtitle{}
  \tiny
\begin{verbatim}
{
    "drugind_id": 22644,
    "efo_id": "EFO:0000341",
    "efo_term": "chronic obstructive pulmonary disease",
    "indication_refs": [
        {
            "ref_id": "NCT00354354,NCT00358488,NCT00359788,...",
            "ref_type": "ClinicalTrials",
            "ref_url": "https://clinicaltrials.gov/search?term=NCT00354354%20NCT00358488%20NCT00359788%20..."
        },
    ]
    "max_phase_for_ind": "4.0",
    "mesh_heading": "Pulmonary Disease, Chronic Obstructive",
    "mesh_id": "D029424",
    "molecule_chembl_id": "CHEMBL714",
    "parent_molecule_chembl_id": "CHEMBL714"
}
\end{verbatim}
\end{frame}

\begin{frame}
  \frametitle{ChEMBL Image for Albuterol}
  \framesubtitle{}
  \begin{figure}
    \begin{center}
      \includegraphics[height=0.8\textheight]{../results/ALBUTEROL-chembl.pdf}
    \end{center}
  \end{figure}
\end{frame}

\begin{frame}
  \frametitle{\href{https://drugs.ncats.io/}{NCATS Inxight Drugs} API
    and Example Use}
  \framesubtitle{See
    \href{https://github.com/ralatsdc/springbok-drug-resource-comparison}{springbok-drug-resource-comparison}
    repository}
  \begin{itemize}
  \item[] \textbf{API}: \href{https://drugs.ncats.io/api}{Inxight} (no repository
    located), and \href{https://github.com/ncats/stitcher}{Stitcher}
    (repository archived)
    \vspace{0.5\baselineskip}
  \item[] \textbf{Usage}: {\texttt ncats.py [-h] [--compound-name COMPOUND\_NAME]
    [-f]}
    \begin{itemize}
    \item Get GSRS data for a compound unique ingredient identifier
    \item Get Stitcher data for a compound unique ingredient identifier
    \item Read Figshare data for a compound unique ingredient identifier
    \item Decode Figshare conditions field
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] \textbf{Performance}: Got NCATS GSRS data for ALBUTEROL in 8 s, and
    Stitcher data for ALBUTEROL in 3 s, although performance varied
  \end{itemize}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol}
  \framesubtitle{}
  \tiny
\begin{verbatim}
{
    "uuid": "7e0fae4c-00c6-4453-a6dc-a60ce10141ae",
    "created": 1743445978000,
    "createdBy": "admin",
    "lastEdited": 1743565750000,
    "lastEditedBy": "admin",
    "deprecated": false,
    "definitionType": "PRIMARY",
    "definitionLevel": "COMPLETE",
    "substanceClass": "chemical",
    "status": "approved",
    "version": "161",
    "approvedBy": "FDA_SRS",
    "names": [...],
    "codes": [...]
    "modifications": {...}
    "notes": [...]
    "properties": [...]
    "approvalID": "QF8SVZ843E",
    "tags": [],
    "structure": {...}
    "moieties": [...]
    "_approvalIDDisplay": "QF8SVZ843E",
    "_name": "ALBUTEROL",
    "access": [],
    "_self": "https://drugs.ncats.io/api/v1/substances(7e0fae4c-00c6-4453-a6dc-a60ce10141ae)?view=full"
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Names}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    "names": [
        {
            "uuid": "16e067cd-7fdd-462c-85a6-ac12f53ab4d8",
            "created": 1743445978000,
            "createdBy": "admin",
            "lastEdited": 1743445978000,
            "lastEditedBy": "admin",
            "deprecated": false,
            "name": "1,3-BENZENEDIMETHANOL, .ALPHA.(SUP 1)-(((1,1-DIMETHYLETHYL)AMINO)METHYL)-4-HYDROXY-",
            "type": "cn",
            "domains": [],
            "languages": [
                "en"
            ],
            "nameJurisdiction": [],
            "nameOrgs": [],
            "preferred": false,
            "displayName": false,
            "references": [
                "b6709ca2-68bc-46bd-bd2f-cb333651db46"
            ],
            "access": [],
            "_self": "https://drugs.ncats.io/api/v1/names(16e067cd-7fdd-462c-85a6-ac12f53ab4d8)?view=full"
        },
    ]
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Codes}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    "codes": [
        {
            "uuid": "1cd3bf3f-6ecd-4a84-8ec7-8a923c037fc8",
            "created": 1743445978000,
            "createdBy": "admin",
            "lastEdited": 1743445978000,
            "lastEditedBy": "admin",
            "deprecated": false,
            "codeSystem": "WHO INTERNATIONAL PHARMACOPEIA",
            "code": "ALBUTEROL",
            "comments": "Description: A white or almost white, crystalline powder; odourless. ...",
            "type": "PRIMARY",
            "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.370.pdf",
            "references": [
                "1545c398-17c3-4d51-a00e-dbcf43cc056a"
            ],
            "access": [],
            "_self": "https://drugs.ncats.io/api/v1/codes(1cd3bf3f-6ecd-4a84-8ec7-8a923c037fc8)?view=full"
        },
    ]
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Modifications}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    "modifications": {
        "uuid": "d4293ed4-cba3-41cc-8c90-afe244780365",
        "created": 1743445978000,
        "createdBy": "admin",
        "lastEdited": 1743445978000,
        "lastEditedBy": "admin",
        "deprecated": false,
        "agentModifications": [],
        "physicalModifications": [],
        "structuralModifications": [],
        "references": [],
        "access": []
    },
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Notes}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    "notes": [
        {
            "uuid": "0b661db6-7f4c-431e-88c5-72d89cb8144d",
            "created": 1743445978000,
            "createdBy": "admin",
            "lastEdited": 1743445978000,
            "lastEditedBy": "admin",
            "deprecated": false,
            "note": "[Validation]WARNING:Code 'QR03AK04'[WHO-VATC] collides (possible duplicate)
                with existing code & codeSystem for substance:\n[Q2WXR1I0PK]CROMOLYN SODIUM",
            "references": [
                "cc331491-ef4a-48c3-9e93-30c9d33aac9a"
            ],
            "access": [
                "admin"
            ]
        },
    ]
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Properties}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "properties": [
        {
            "uuid": "3996b30a-6ff4-47c6-9b94-4dc364d75960",
            "created": 1743445978000,
            "createdBy": "admin",
            "lastEdited": 1743445978000,
            "lastEditedBy": "admin",
            "deprecated": false,
            "name": "Volume of Distribution",
            "propertyType": "PHARMACOKINETIC",
            "value": {
                "uuid": "cb7ae50b-e777-4eb3-a349-809e4610b997",
                "created": 1743445978000,
                "createdBy": "admin",
                "lastEdited": 1743445978000,
                "lastEditedBy": "admin",
                "deprecated": false,
                "average": 3.4,
                "units": "Liters/Kilogram",
                "references": [],
                "access": []
            },
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
            "defining": false,
            "parameters": [],
            "references": [
                "b6340555-7138-c54c-c98f-2f086ba11246"
            ],
            "access": []
        },
    ]
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Structure}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "structure": {
        "id": "5a129248-bc18-4545-99a1-5d175834c363",
        "created": 1743445978000,
        "lastEdited": 1743445978000,
        "deprecated": false,
        "digest": "0dc449888fa8e42de5c7e5f7b60941364bfadb55",
        "molfile": "...",
        "smiles": "CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1",
        "formula": "C13H21NO3",
        "opticalActivity": "( + / - )",
        "atropisomerism": "No",
        "stereoCenters": 1,
        "definedStereo": 0,
        "ezCenters": 0,
        "charge": 0,
        "mwt": 239.3107,
        "count": 1,
        "createdBy": "admin",
        "lastEditedBy": "admin",
        "hash": "RJYZJCG7HWL2",
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
        "self": "https://drugs.ncats.io/api/v1/structures
            (5a129248-bc18-4545-99a1-5d175834c363)?view=full",
        "stereochemistry": "RACEMIC",
        "references": [
            "42aba274-8264-4ecf-a4a0-59adad9b98c6",
            "0b8676bd-1f66-4f1f-9737-97a3e13a2d31",
            "82199cff-aff9-4ca9-9948-baf170553652"
        ],
        "access": []
    },
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs GSRS Data for Albuterol: Moieties}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
    "moieties": [
        {
            "uuid": "75edf16e-1c0b-4ba3-aa75-5985d23c30b0",
            "created": 1743445979000,
            "createdBy": "admin",
            "lastEdited": 1743445979000,
            "lastEditedBy": "admin",
            "deprecated": false,
            "id": "75edf16e-1c0b-4ba3-aa75-5985d23c30b0",
            "digest": "036ea932aac80052cab2f56f97d446eb52ebbf6d",
            "molfile": "...",
            "smiles": "CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1",
            "formula": "C13H21NO3",
            "opticalActivity": "( + / - )",
            "atropisomerism": "No",
            "stereoCenters": 1,
            "definedStereo": 0,
            "ezCenters": 0,
            "charge": 0,
            "mwt": 239.3107,
            "count": 1,
            "hash": "RJYZJCG7HWL2",
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
            "self": "https://drugs.ncats.io/api/v1/structures
                (75edf16e-1c0b-4ba3-aa75-5985d23c30b0)?view=full",
            "stereochemistry": "RACEMIC",
            "references": [],
            "access": [],
            "countAmount": {
                "uuid": "1b01d0ee-8b2d-4b14-9b7e-2e4fd65f8ae9",
                "created": 1743445979000,
                "createdBy": "admin",
                "lastEdited": 1743445979000,
                "lastEditedBy": "admin",
                "deprecated": false,
                "type": "MOL RATIO",
                "average": 1.0,
                "units": "MOL RATIO",
                "references": [],
                "access": []
            }
        }
    ]
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs Stitcher Data for Albuterol: PubMed (1 of 2)}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
{
    "name": "PubMed",
    "value": {
        "uid": "14657817",
        "pubdate": "2003 Dec",
        "epubdate": "",
        "source": "J Pediatr",
        "authors": [
            {
                "name": "Carl JC",
                "authtype": "Author",
                "clusterid": ""
            },
        ],
        "lastauthor": "Kercsmar CM",
        "title": "Comparison of racemic albuterol and
            levalbuterol for treatment of acute asthma.",
        "sorttitle": "comparison of racemic albuterol and
            levalbuterol for treatment of acute asthma",
        "volume": "143",
        "issue": "6",
        "pages": "731-6",
        "lang": [
            "eng"
        ],
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
        "nlmuniqueid": "0375410",
        "issn": "0022-3476",
        "essn": "",
        "pubtype": [
            "Clinical Trial",
            "Journal Article",
            "Randomized Controlled Trial"
        ],
        "recordstatus": "PubMed - indexed for MEDLINE",
        "pubstatus": "4",
        "articleids": [
            {
                "idtype": "pubmed",
                "idtypen": 1,
                "value": "14657817"
            },
        ],
        "history": [
            {
                "pubstatus": "pubmed",
                "date": "2003/12/06 05:00"
            },
        ],
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs Stitcher Data for Albuterol: PubMed (2 of 2)}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.6\textwidth}
\begin{verbatim}
        "references": [
            {
                "refsource": "J Pediatr. 2003 Dec;143(6):702-4.
                    doi: 10.1016/j.jpeds.2003.10.018.",
                "reftype": "Comment in",
                "pmid": 14657810,
                "note": ""
            },
        ],
        "attributes": [
            "Has Abstract"
        ],
        "pmcrefcount": "",
        "fulljournalname": "The Journal of pediatrics",
\end{verbatim}
    \end{column}
    \begin{column}{0.4\textwidth}
\begin{verbatim}
        "elocationid": "",
        "doctype": "citation",
        "srccontriblist": [],
        "booktitle": "",
        "medium": "",
        "edition": "",
        "publisherlocation": "",
        "publishername": "",
        "srcdate": "",
        "reportnumber": "",
        "availablefromurl": "",
        "locationlabel": "",
        "doccontriblist": [],
        "docdate": "",
        "bookname": "",
        "chapter": "",
        "sortpubdate": "2003/12/01 00:00",
        "sortfirstauthor": "Carl JC",
        "vernaculartitle": ""
    }
},
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs Stitcher Data for Albuterol: Description and Phase}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    {
        "value": {
            "description": "Levalbuterol is the (R)-enantiomer of the drug substance racemic albuterol
                 (salbutamol). Binding studies have demonstrated that (R)-albuterol binds to the beta2-adrenergic
                 receptor with a high affinity, whereas (S)-albuterol binds with 100-fold less affinity than
                 (R)-albuterol. Other evaluations have suggested that (R)-albuterol possesses the bronchodilatory,
                 bronchoprotective, and ciliary-stimulatory properties of racemic albuterol, while (S)-albuterol
                 does not beneficially to the therapeutic effects of the racemate and was originally assumed
                 to be inert. Xopenex (levalbuterol HCl) Inhalation Solution is indicated for the treatment
                 or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older
                 with reversible obstructive airway disease.",
            "uri": [
                "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020837s036lbl.pdf |
                    https://www.ncbi.nlm.nih.gov/pubmed/15293593 |
                    https://www.ncbi.nlm.nih.gov/pubmed/10452786"
            ]
        },
        "name": "Description"
    },
    {
        "value": {
            "highestPhase": "Approved"
        },
        "name": "Stitcher Highest Phase"
    },
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs Stitcher Data for Albuterol: Targets and Conditions}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
    \vspace{-3\baselineskip}
\begin{verbatim}
{
    "name": "Targets"
    "value": {
        "StitcherId": "17288.0",
        "id": "CHEMBL210",
        "label": "Beta-2 adrenergic receptor",
        "type": "ChEMBL",
        "pharmacology": "Agonist",
        "potencyType": "Kd",
        "potencyValue": "236.0",
        "potencyDimensions": "nM",
        "potencyUri": "https://www.ncbi.nlm.nih.gov/pubmed/8866170",
        "uri": [
            "https://www.accessdata.fda.gov/drugsatfda_docs/label/
                2012/020837s036lbl.pdf"
        ],
        "condition_refs": null,
        "conditions": []
    },
}
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
      \vspace{-3\baselineskip}
\begin{verbatim}
{
    "name": "Conditions"
    "value": {
        "StitcherId": "17648.0",
        "label": "Asthma",
        "uri": [
            "https://www.ncbi.nlm.nih.gov/pubmed/15293593 ",
            "http://adisinsight.springer.com/drugs/800005434"
        ],
        "highestPhase": "Approved",
        "highestPhaseUri": "https://www.accessdata.fda.gov/
            scripts/cder/ob/results_product.cfm?
            Appl_Type=N&Appl_No=020837",
        "modality": "Primary",
        "productName": "XOPENEX",
        "productFDAUse": "XOPENEX (levalbuterol HCl) Inhalation
            Solution Concentrate is indicated for the treatment
            or prevention of bronchospasm in adults, ...",
        "productFDAUseUri": "https://www.accessdata.fda.gov/
            drugsatfda_docs/label/2012/020837s036lbl.pdf",
        "productDate": "9.2231998E11",
        "isHighestPhaseApproved": "true",
        "approvalSource": "RANCHO",
        "target_refs": null,
        "targets": []
    },
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{NCATS Inxight Drugs FigShare Conditions for Albuterol}
  \framesubtitle{}
  \tiny
\begin{verbatim}
    "condition_id": 17648,
    "name": "Asthma",
    "condition_uri": "https://www.ncbi.nlm.nih.gov/pubmed/15293593 | ...",
    "condition_comment": " ",
    "product_name": "XOPENEX",
    "product_date": 922320000000,
    "condition_highest_phase": "Approved",
    "highest_phase_uri": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?...",
    "fda_use": "XOPENEX (levalbuterol HCl) Inhalation Solution Concentrate is indicated for the
        treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of
        age and older with reversible obstructive airway disease.",
    "offlabel_use": "Unknown",
    "offlabel_use_uri": "Unknown",
    "offlabel_use_comment": " ",
    "clinical_trial": "NCT00667797",
    "condition_treatment_modality": "Primary",
    "condition_do_imprecise": false,
    "condition_mesh_imprecise": false,
    "mesh_id": "D001249",
    "mesh_label": "Asthma",
    "do_id": "2841",
    "do_label": "asthma",
    "is_fda_use": true,
    "fda_use_uri": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020837s036lbl.pdf",
    "is_product_manual": false,
    "highest_phase_discontinued": false,
    "product_discontinued": false,
    "is_product_date_unknown": false
\end{verbatim}
\end{frame}

\begin{frame}
  \frametitle{\href{https://platform-docs.opentargets.org/getting-started}{Open
      Targets Platform} API and Example Use}
  \framesubtitle{See
    \href{https://github.com/ralatsdc/springbok-drug-resource-comparison}{springbok-drug-resource-comparison}
    repository}
  \begin{itemize}\footnotesize
  \item[] \textbf{API}: \href{https://github.com/pachterlab/gget}{gget}
    (repository actively developed), and Open Targets
    \href{https://platform.opentargets.org/api}{API Description},
    \href{https://platform-docs.opentargets.org/data-access/graphql-api}{GraphQL
      API},
    \href{https://api.platform.opentargets.org/api/v4/graphql/browser}{GraphQL
      API playground}, and
    \href{https://github.com/opentargets/platform-api}{repository}
    (actively developed)
    \vspace{0.5\baselineskip}
  \item[] \textbf{Usage}: {\texttt gget\_cli.py $|$ open\_targets.py [-h]
    [--gene-symbol GENE\_SYMBOL]}
    \begin{itemize}\scriptsize
    \item Find targets associated with a specific disease or phenotype
    \item Find diseases and phenotypes associated with a specific
      target
    \item Explore evidence that supports a specific target-disease
      association
    \item Find tractability and safety information for a specific
      target
    \item Find clinical signs and symptoms for a specific disease
    \item GWAS studies associated with a specified disease
    \item Find indications for a specific drug
    \item Credible sets from quantitative trait loci associated with
      molecular traits containing a specified variant
    \item Information about a specified study
    \item Colocalisation metrics for overlapping credible sets from
      GWAS studies
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] \textbf{Performance}: Got gget data for ADRB2 in 2 s, got Open
    Targets data for ADRB2, and ALBUTEROL in less than 1 s
  \end{itemize}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Targets associated with a disease}
  \framesubtitle{}
  \tiny
\begin{verbatim}
"disease": {
    "id": "MONDO_0004979",
    "name": "asthma",
    "associatedTargets": {
        "count": 3039,
        "rows": [
            {
                "target": {
                    "id": "ENSG00000169252",
                    "approvedSymbol": "ADRB2"
                },
                "score": 0.6148856746523589
            },
        ]
    }
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Diseases associated with a target}
  \framesubtitle{}
  \tiny
\begin{verbatim}
"target": {
    "id": "ENSG00000169252",
    "approvedSymbol": "ADRB2",
    "associatedDiseases": {
        "count": 829,
        "rows": [
            {
                "disease": {
                    "id": "MONDO_0004979",
                    "name": "asthma"
                },
                "datasourceScores": [
                    {
                        "id": "chembl",
                        "score": 0.9988218092809733
                    },
                ]
            },
        ]
    }
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Evidence for target-disease association}
  \framesubtitle{}
  \tiny
\begin{verbatim}
"disease": {
    "id": "MONDO_0004979",
    "name": "asthma",
    "evidences": {
        "count": 917,
        "rows": [
            {
                "disease": {
                    "id": "MONDO_0004979",
                    "name": "asthma"
                },
                "diseaseFromSource": "bronchospasm",
                "target": {
                    "id": "ENSG00000169252",
                    "approvedSymbol": "ADRB2"
                },
                "mutatedSamples": null,
                "resourceScore": null,
                "significantDriverMethods": null,
                "cohortId": null,
                "cohortShortName": null,
                "cohortDescription": null
            },
        ]
    }
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Tractability and safety information for a target}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.3\textwidth}
\begin{verbatim}
"target": {
    "id": "ENSG00000169252",
    "approvedSymbol": "ADRB2",
    "tractability": [
        {
            "modality": "SM",
            "label": "Approved Drug",
            "value": true
        },
    ],
\end{verbatim}
    \end{column}
    \begin{column}{0.7\textwidth}
\begin{verbatim}
    "safetyLiabilities": [
        {
            "event": "cardiac contractility",
            "eventId": "GO_0045823",
            "biosamples": [
                {
                    "cellFormat": null,
                    "cellLabel": null,
                    "tissueLabel": "cardiovascular system",
                    "tissueId": "UBERON_0004535"
                }
            ],
            "effects": [
                {
                    "dosing": "general",
                    "direction": "Activation/Increase/Upregulation"
                }
            ],
            "studies": null,
            "datasource": "Urban et al. (2012)",
            "literature": null
        },
    ]
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Clinical signs and symptoms for a disease}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.4\textwidth}
\begin{verbatim}
"disease": {
    "id": "MONDO_0004979",
    "name": "asthma",
    "phenotypes": {
        "count": 5,
        "rows": [
            {
                "phenotypeHPO": {
                    "id": "HP_0032933",
                    "name": "Airway hyperresponsiveness",
                    "description": "An increased sensitivity of
                        the airways to an inhaled constrictor agonist,
                        a steeper slope of the dose-response curve,
                        and a greater maximal response to the agonist.",
                    "namespace": null
                },
\end{verbatim}
    \end{column}
    \begin{column}{0.6\textwidth}
\begin{verbatim}
                "phenotypeEFO": null,
                "evidence": [
                    {
                        "aspect": "P",
                        "bioCuration": "HPO:probinson[2022-04-15]",
                        "diseaseFromSourceId": "OMIM:600807",
                        "diseaseFromSource": "Asthma, susceptibility to",
                        "evidenceType": "TAS",
                        "frequency": null,
                        "frequencyHPO": null,
                        "qualifierNot": false,
                        "onset": [],
                        "modifiers": [],
                        "references": [
                            "OMIM:600807"
                        ],
                        "sex": null,
                        "resource": "HPO"
                    }
                ]
            },
        ]
    }
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: GWAS studies associated with a disease}
  \framesubtitle{diseaseId: MONDO\_0004979}
  \tiny
\begin{verbatim}
"studies": {
    "count": 175,
    "rows": [
        {
            "id": "GCST90255360",
            "projectId": "GCST",
            "traitFromSource": "Asthma",
            "publicationFirstAuthor": "Do AR",
            "publicationDate": "2022-12-21",
            "publicationJournal": "Sci Rep",
            "nSamples": 6737,
            "cohorts": [
                "NR"
            ],
            "pubmedId": "36543808",
            "ldPopulationStructure": [
                {
                    "ldPopulation": "eas",
                    "relativeSampleSize": 1
                }
            ]
        },
    ]
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Indications for a drug}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
      \vspace{-2\baselineskip}
\begin{verbatim}
"drug": {
    "name": "ALBUTEROL",
    "id": "CHEMBL714",
    "isApproved": true,
    "indications": {
        "count": 35,
        "rows": [
            {
                "maxPhaseForIndication": 4,
                "references": [
                    {
                        "source": "DailyMed",
                        "ids": [
                            "29d24a6d-f9c1-4300-97c7-fec26bdbc22b"
                        ]
                    }
                ],
                "disease": {
                    "id": "MONDO_0004979",
                    "name": "asthma",
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
      \vspace{-2\baselineskip}
\begin{verbatim}
                    "dbXRefs": [
                        "ICD9:493.81",
                        "UMLS:C0004096",
                        "DOID:2841",
                        "ICD9:493.9",
                        "ICD9:493",
                        "NCIT:C28397",
                        "icd11.foundation:1656445230",
                        "MESH:D001249",
                        "SCTID:31387002",
                        "HP:0002099",
                        "ICD10CM:J45",
                        "MEDGEN:2109"
                    ],
                    "literatureOcurrences": {
                        "count": 32368,
                        "rows": [
                            {
                                "pmid": "25671117",
                                "pmcid": "PMC4323120",
                                "publicationDate": "2015-01-01"
                            },
                        ]
                    }
                }
            },
        ]
    }
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

%% \begin{frame}[fragile,t]
%%   \frametitle{Open Targets: Approval status, and withdrawn and black-box warning for a drug}
%%   \framesubtitle{}
%%   \tiny
%% \begin{verbatim}
%% "drug": {
%%     "name": "ALBUTEROL",
%%     "id": "CHEMBL714",
%%     "isApproved": true,
%%     "hasBeenWithdrawn": false,
%%     "blackBoxWarning": true,
%%     "drugWarnings": [
%%         {
%%             "warningType": "Black Box Warning",
%%             "description": null,
%%             "toxicityClass": null,
%%             "year": null,
%%             "references": [
%%                 {
%%                     "id": "8c278b6f-d32b-b750-e053-2995a90ad7e9",
%%                     "source": "DailyMed",
%%                     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c278b6f-d32b-b750-e053-2995a90ad7e9"
%%                 },
%%             ]
%%         },
%%     ]
%% }
%% \end{verbatim}
%% \end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Credible sets from quantitative trait loci associated with molecular traits containing a variant}
  \framesubtitle{}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.3\textwidth}
\begin{verbatim}
"variant": {
    "id": "1_152312600_CACTG_C",
    "qtlCredibleSets": {
        "count": 1,
        "rows": [
            {
                "studyLocusId":
                    "4fea74b7dcc65149b658a71b5c5fa0f3",
                "pValueMantissa": 3.322999954223633,
                "pValueExponent": -7,
                "beta": -0.839744,
                "finemappingMethod": "SuSie",
                "confidence":
                    "SuSiE fine-mapped credible set
                    with in-sample LD",
                "variant": {
                    "id": "1_152057072_G_A",
                    "chromosome": "1"
                },
\end{verbatim}
    \end{column}
    \begin{column}{0.7\textwidth}
\begin{verbatim}
                "study": {
                    "id": "gtex_exon_stomach_ensg00000143376_14_1_151693484_151693543",
                    "studyType": "eqtl",
                    "condition": "naive",
                    "target": {
                        "id": "ENSG00000143376",
                        "approvedSymbol": "SNX27"
                    },
                    "biosample": {
                        "biosampleId": "UBERON_0000945",
                        "biosampleName": "stomach"
                    }
                },
                "locus": {
                    "count": 0,
                    "rows": null
                },
                "locusSize": {
                    "count": 2
                }
            }
        ]
    }
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Information about a study}
  \framesubtitle{}
  \tiny
\begin{verbatim}
"studies": {
    "count": 1,
    "rows": [
        {
            "id": "gtex_exon_stomach_ensg00000143376_14_1_151693484_151693543",
            "studyType": "eqtl",
            "traitFromSource": "ENSG00000143376.14_1_151693484_151693543",
            "projectId": "GTEx",
            "diseases": [],
            "publicationFirstAuthor": null,
            "publicationDate": null,
            "publicationJournal": null,
            "pubmedId": "32913098",
            "nSamples": 324,
            "cohorts": null,
            "ldPopulationStructure": null
        }
    ]
}
\end{verbatim}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Open Targets: Colocalisation metrics for overlapping credible sets}
  \framesubtitle{studyLocusId: 4fea74b7dcc65149b658a71b5c5fa0f3}
  \tiny
  \begin{columns}[t]
    \begin{column}{0.5\textwidth}
\begin{verbatim}
"credibleSet": {
    "colocalisation": {
        "count": 18,
        "rows": [
            {
                "otherStudyLocus": {
                    "studyLocusId":
                        "d3ef302b201c3fbc4fc972ebfe4fad0b",
                    "study": {
                        "id": "FINNGEN_R12_L12_FOODDERMAT",
                        "projectId": "FINNGEN_R12",
                        "traitFromSource":
                            "Dermatitis due to ingested food",
                        "publicationFirstAuthor": null
                    },
                    "variant": {
                        "id": "1_152312600_CACTG_C",
                        "chromosome": "1",
                        "position": 152312600,
                        "referenceAllele": "CACTG",
                        "alternateAllele": "C"
                    },
                    "pValueMantissa": 2.427999973297119,
                    "pValueExponent": -8
                },
\end{verbatim}
    \end{column}
    \begin{column}{0.5\textwidth}
\begin{verbatim}
                "numberColocalisingVariants": 1,
                "colocalisationMethod": "COLOC",
                "h3": 0.005138319255541063,
                "h4": 0.9944360622406548,
                "clpp": null,
                "betaRatioSignAverage": -1
            },
        ]
    }
}
\end{verbatim}
    \end{column}
  \end{columns}
\end{frame}

\begin{frame}[fragile,t]
  \frametitle{Observations and Next Step}
  \frametitle{}
  \framesubtitle{}
  \begin{itemize}
  \item[] Open Targets appears to offer the most comprehensive
    resource
    \begin{itemize}
    \item Includes ChEMBL indications data
    \item Like NCATS Inxight Drugs, includes PubMed and PubMed Central
      data
    \item Includes GWAS data
    \end{itemize}
    \vspace{0.5\baselineskip}
  \item[] Open Targets data appears well organized, and easily
    accessible using GraphQL
    \vspace{0.5\baselineskip}
  \item[] Open Targets is supported by the largest team, and appears
    to be actively developed
    \vspace{0.5\baselineskip}
  \item[] Next step for team: review and select data elements from
    each resource
    \href{https://drive.google.com/drive/u/0/folders/1oWTGj9LLKeqklSrDB97kliZlKHrgdBKo}{here}
  \end{itemize}
\end{frame}

%% f
%% \begin{frame}
%%   \frametitle{}
%%   \framesubtitle{}
%% \end{frame}

%% i
%% \begin{itemize}
%% \item[]
%% \end{itemize}

%% e
%% \begin{enumerate}
%% \item
%% \item
%% \end{enumerate}

%% c
%% \begin{columns}
%%   \begin{column}{0.5\textwidth}
%%   \end{column}
%%   \begin{column}{0.5\textwidth}
%%   \end{column}
%% \end{columns}

%% g
%% \begin{frame}
%%   \frametitle{}
%%   \framesubtitle{}
%%   \begin{figure}
%%     \begin{center}
%%       \includegraphics[height=0.8\textheight]{}
%%     \end{center}
%%   \end{figure}
%% \end{frame}

%% b
%% \begin{frame}
%%   \frametitle{}
%%   \framesubtitle{}
%%   \begin{table}
%%     \begin{center}
%%       \input{}
%%     \end{center}
%%   \end{table}
%% \end{frame}

\end{document}
